Related Experiment Video
Updated: Apr 15, 2026

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification
Xin Li1, Jina Lim2, Jinxiu Lu3
1Department of Medicine, University of California, Los Angeles, California.
Insights
Inhibitory Smad6, a key regulator in vascular calcification, is reduced by tumor necrosis factor alpha (TNF-α). This reduction promotes inflammation-induced calcific aortic and valvular disease (CAVD) by upregulating BMP-2 signaling.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Biochemistry
Background:
- Calcific aortic and valvular disease (CAVD) is linked to hyperlipidemia and chronic inflammation.
- Inhibitory Smad proteins (I-Smads), specifically Smad6 and Smad7, are implicated in valve development and potentially CAVD.
- The role of I-Smads in inflammation-driven calcific vasculopathy remains unclear.
Purpose of the Study:
- To investigate the role of I-Smads in the pathogenesis of atherosclerotic calcification.
- To determine if Smad6 and Smad7 expression is altered in hyperlipidemia-associated CAVD.
- To elucidate the mechanism by which inflammatory cytokines influence valvular interstitial cells (VICs) and CAVD.
Main Methods:
- Comparative analysis of Smad6 and Smad7 expression in hyperlipidemic versus normolipemic mouse models.
- Culture and treatment of murine aortic valve interstitial cells (mVICs) with tumor necrosis factor alpha (TNF-α).
- Assessment of alkaline phosphatase (ALP) activity, matrix mineralization, and gene expression (BMP-2, Wnt, redox-regulated genes) in mVICs.
- Smad6 knockdown using lentiviral shRNA to evaluate its specific role in TNF-α-induced calcification.
Main Results:
- Smad6 expression was significantly reduced in aortic and valve tissues of hyperlipidemic mice, correlating with increased TNF-α.
- TNF-α treatment of mVICs upregulated ALP activity, matrix mineralization, and BMP-2 expression, while downregulating Smad6.
- Smad6 knockdown exacerbated TNF-α-induced calcification and BMP-2 upregulation in mVICs, indicating a critical inhibitory role for Smad6.
- Smad7 expression was not significantly affected by TNF-α or hyperlipidemia.
Conclusions:
- TNF-α promotes valvular and vascular cell calcification, partly by specifically decreasing Smad6 expression.
- Reduced Smad6 levels enhance BMP-2 signaling, contributing to the development of calcific aortic and valvular disease.
- Smad6 acts as a crucial endogenous inhibitor of inflammation-induced calcification in the aortic valve.
Abstract:
Calcific aortic vascular and valvular disease (CAVD) is associated with hyperlipidemia, the effects of which occur through chronic inflammation. Evidence suggests that inhibitory small mothers against decapentaplegic (I-Smads; Smad6 and 7) regulate valve embryogenesis and may serve as a mitigating factor in CAVD. However, whether I-Smads regulate inflammation-induced calcific vasculopathy is not clear. Therefore, we investigated the role of I-Smads in atherosclerotic calcification. Results showed that expression of Smad6, but not Smad7, was reduced in aortic and valve tissues of hyperlipidemic compared with normolipemic mice, while expression of tumor necrosis factor alpha (TNF-α) was upregulated. To test whether the effects are in response to inflammatory cytokines, we isolated murine aortic valve leaflets and cultured valvular interstitial cells (mVIC) from the normolipemic mice. By immunochemistry, mVICs were strongly positive for vimentin, weakly positive for smooth muscle α actin, and negative for an endothelial cell marker. TNF-α upregulated alkaline phosphatase (ALP) activity and matrix mineralization in mVICs. By gene expression analysis, TNF-α significantly upregulated bone morphogenetic protein 2 (BMP-2) expression while downregulating Smad6 expression. Smad7 expression was not significantly affected. To further test the role of Smad6 on TNF-α-induced valvular cell calcification, we knocked down Smad6 expression using lentiviral transfection. In cells transfected with Smad6 shRNA, TNF-α further augmented ALP activity, expression of BMP-2, Wnt- and redox-regulated genes, and matrix mineralization compared with the control cells. These findings suggest that TNF-α induces valvular and vascular cell calcification, in part, by specifically reducing the expression of a BMP-2 signaling inhibitor, Smad6.
Related Concept Videos
TGF - β Signaling Pathway
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway
Atherosclerosis I: Introduction

